The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The negative impact of antibiotic resistance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Self-citationFalagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Enright, M. C., Robinson, D. A., Randle, G., Feil, E. J., Grundmann, H., & Spratt, B. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122108599 · Cited by 1,588
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
Unemo, M., & Shafer, W. M. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-14 · Cited by 1,151
Bartlett, J. G., & Mundy, L. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332408 · Cited by 982
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Self-citationPatel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/592412 · Cited by 836
Shlaes, D. M., Gerding, D. N., John, Jr., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 780
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Self-citationSchwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Self-citationDoern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1721-1729.2001 · Cited by 538
Yu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., Schlaeffer, F., & Sherf, M. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/605922 · Cited by 389
Teillant, A., Gandra, S., Barter, D., Morgan, D. J., & Laxminarayan, R. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00270-4 · Cited by 379
The growing burden of antimicrobial resistance
Hawkey, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn241 · Cited by 377
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., & Rahav, G. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03478.x · Cited by 353
Wagenlehner, F. M. E., van Oostrum, E., Tenke, P., Tandogdu, Z., Çek, M., Grabe, M., Wullt, B., Pickard, R., Naber, K. G., Pilatz, A., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.06.003 · Cited by 335
Melzer, M., & Petersen, I. (2007) · Journal of Infection · doi:10.1016/j.jinf.2007.04.007 · Cited by 298
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Mouton, J. W., Brown, D. F. J., Apfalter, P., Cantón, R., Giske, C. G., Ivanova, M., MacGowan, A. P., Rodloff, A., Soussy, C.-J., Steinbakk, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03752.x · Cited by 286
Metlay, J. P., Hofmann, J., Cetron, M. S., Fine, M. J., Farley, M. M., Whitney, C., & Breiman, R. F. (2000) · Clinical Infectious Diseases · doi:10.1086/313716 · Cited by 270
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228
Rottier, W. C., Ammerlaan, H. S. M., & Bonten, M. J. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks065 · Cited by 225
Wyllie, D. H., Crook, D. W., & Peto, T. E. A. (2006) · BMJ · doi:10.1136/bmj.38834.421713.2f · Cited by 210
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Girmenia, C., Rossolini, G. M., Piciocchi, A., Bertaina, A., Pisapia, G., Pastore, D., Sica, S., Severino, A., Cudillo, L., Ciceri, F., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.231 · Cited by 189
Alexander, B. D., Petzold, E. W., Reller, L. B., Palmer, S. M., Davis, R. D., Woods, C. W., & LiPuma, J. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02186.x · Cited by 177
Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults
Courtney, J. M., Dunbar, K. E. A., McDowell, A., Moore, J. E., Warke, T. J., Stevenson, M., & Elborn, J. S. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.01.005 · Cited by 168
Williamson, D. A., Barrett, L. K., Rogers, B. A., Freeman, J. T., Hadway, P., & Paterson, D. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit193 · Cited by 153
Cecchini, M., Langer, J., & Slawomirski, L. (2015) · Cited by 134
Consequences of Bacterial Resistance to Antibiotics in Medical Practice
Acar, J. F. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s17 · Cited by 123
Paterson, D. L. (2008) · Clinical Infectious Diseases · doi:10.1086/590062 · Cited by 99
Macrae, M. B., Shannon, K. P., Rayner, D., Kaiser, A. M., Hoffman, P. N., & French, G. L. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1066 · Cited by 95
Nutman, A., Glick, R., Temkin, E., Hoshen, M., Edgar, R., Braun, T., & Carmeli, Y. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12716 · Cited by 81
Self-citationStaphylococcus aureus and Vancomycin: The Sequel
Karchmer, A. W. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-739 · Cited by 78
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis
Bogan, C., Kaye, K. S., Chopra, T., Hayakawa, K., Pogue, J. M., Lephart, P., Bheemreddy, S., Lazarovitch, T., Zaidenstein, R., Pérez, F., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.02.013 · Cited by 51
Kim, J., Kang, C., Joo, E., Ha, Y. E., Cho, S. Y., Gwak, G., Chung, D. R., Peck, K. R., & Song, J. (2013) · Liver International · doi:10.1111/liv.12374 · Cited by 43
Newman, W., Torres, J. M., & Guck, J. K. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90369-1 · Cited by 30
Cited by
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
“Treating patients with resistant infections by using a combination of regimens may be ineffective; as a result, compared to other patients, they may need longer hospitalization stays as well as more intensive care units (ICUs) and isolation beds in order to prevent the spread of the infection.(55) Also, nosocomial out…”
BackgroundResultInfluentialAn overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Manyi-Loh, C., Mamphweli, S., Meyer, E., & Okoh, A. (2018) · Molecules · doi:10.3390/molecules23040795 · Cited by 1,808
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Hyde, K. D., Xu, J., Rapior, S., Jeewon, R., Lumyong, S., Niego, A. G. T., Abeywickrama, P. D., Aluthmuhandiram, J. V. S., Brahamanage, R. S., Brooks, S., et al. (2019) · Fungal Diversity · doi:10.1007/s13225-019-00430-9 · Cited by 811
Metadata
- Authors
- Friedman, N. D., Temkin, E., & Carmeli, Y.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 22
- Issue
- 5
- Pages
- 416-422
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2215646221
- Cited by
- 870
- References
- 43
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.